Sutter Health Research Enterprise
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 454-6822
simr@sutterhealth.org
Dr. Rohatgi is a research oncologist at SIMR.
Sutter Health Research Enterprise
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 454-6822
simr@sutterhealth.org
Sutter Health Research Enterprise
2800 L Street, Suite 300
Sacramento, CA, 95816
(916) 454-6822
simr@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Lung Cancer (AbbVie M14-239)
Study of Telisotuzumab Vedotin (ABBV-399) in Subjects With Previously Treated c-Met+
Non-Small Cell Lung Cancer
Investigators: Deepti Behl MD, Nitin Rohatgi MD
Status: Active, Recruiting
Novocure LUNAR
Effect of Tumor Treating Fields Concurrent W/ Standard of Care Therapies for Treatment
of Stage 4 NSCLC following Platinum Failure (LUNAR)
Investigators: Deepti Behl MD, Stacy D'Andre MD, Nitin Rohatgi MD, Melissa Williams M.D.
Status: Active, Recruiting
Publications
Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.
Raloxifene is associated with less side effects than tamoxifen in women with early
breast cancer: a questionnaire study from one physician's practice.
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide,
mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas
Research Studies
Genomic Health Oncotype DX AR-V7
Genomic Health 09-060
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D., David Yee M.D., MPH
POLARIS Palbociclib in Real World Practice
Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter
Non-Interventional Study
Investigators: Kristin N. Arreola M.D., Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Brian K. Kim M.D, Sivakumar Reddy M.D., Nitin Rohatgi MD, Vijay Suhag M.D.